An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5

An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5

IntroductionUnderstanding the immune status of an individual using neutralizing antibody testing is complicated by the continued evolution of the SARS-CoV-2 virus. Previous work showed that assays developed against the wildtype strain of SARS-CoV-2 were insufficient predictors of neutralization of o...

Full description

Bibliographic Details
Main Authors:	Stephen Varvel, Marzena Galdzicka, Stephanie Nystrom, Hong Liu, Ge Chen, Izabela Ragan, Shahrokh Shabahang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Immunology
Subjects:	SARS-CoV-2 omicron neutralizing antibody flow cytometry XBB.1.5
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1334250/full

Similar Items

Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping
by: Masaud Shah, et al.
Published: (2023-09-01)

Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges
by: Thirumalaisamy P. Velavan, et al.
Published: (2023-03-01)

Monovalent XBB.1.5 booster vaccination induces a broad spectrum of SARS-CoV-2 neutralizing antibodies
by: Nan Huo, et al.
Published: (2024-12-01)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01)

The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of a few cases
by: Jasmine Samal, et al.
Published: (2023-06-01)

Simultaneous measurement of multiple variant-specific SARS-CoV-2 neutralizing antibodies with a multiplexed flow cytometric assay
by: Hong Liu, et al.
Published: (2022-11-01)

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
by: Cai He, et al.
Published: (2023-06-01)

Distinctive Features of the XBB.1.5 and XBB.1.16 Spike Protein Receptor-Binding Domains and Their Roles in Conformational Changes and Angiotensin-Converting Enzyme 2 Binding
by: Tej Sharma, et al.
Published: (2023-08-01)

The Omicron XBB.1 Variant and Its Descendants: Genomic Mutations, Rapid Dissemination and Notable Characteristics
by: Raffaele Giancotti, et al.
Published: (2024-02-01)

XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
by: Md. Aminul Islam, et al.
Published: (2023-04-01)

Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster
by: Rafael Rahal Guaragna Machado, et al.
Published: (2024-01-01)

Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster
by: Julien Favresse, et al.
Published: (2024-06-01)

An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants
by: Zongming Liu, et al.
Published: (2023-12-01)

Transmission and re-infection of Omicron variant XBB.1.5 in hamstersResearch in context
by: Peter J. Halfmann, et al.
Published: (2023-07-01)

Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon
by: Ibrahim Al Kodsi, et al.
Published: (2024-01-01)

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
by: Hsiao-Ling Chiang, et al.
Published: (2023-07-01)

Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA
by: Arunachalam Ramaiah, et al.
Published: (2023-09-01)

XBB.1.16 Omicron subvariant rise to a variant of interest: Implications for global alertness and preparedness
by: Okesanya Olalekan John, B'MLS, et al.
Published: (2023-12-01)

Twitter-Based Sentiment Analysis and Topic Modeling of Social Media Posts using Natural Language Processing, to Understand People’s Perspectives Regarding COVID-19 Omicron Subvariants XBB.1.5 and BF.7
by: S.V. Praveen, et al.
Published: (2023-03-01)

The assessment of Twitter discourse on the new COVID-19 variant, XBB.1.5, through social network analysis
by: Ikhwan Yuda Kusuma, et al.
Published: (2023-08-01)

Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters
by: Sreelekshmy Mohandas, et al.
Published: (2023-06-01)

Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5
by: Fabio Scarpa, et al.
Published: (2023-03-01)

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
by: Romal Stewart, et al.
Published: (2023-11-01)

Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice
by: Jian-Piao Cai, et al.
Published: (2023-03-01)

SARS‐CoV‐2 Omicron variants in Bangladesh: Pandemic to endemic
by: Mohammad Jubair, et al.
Published: (2023-03-01)

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
by: Bradley K. Ackerson, et al.
Published: (2024-12-01)

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
by: Julia N. Faraone, et al.
Published: (2023-12-01)

Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
by: Silvia Sutandhio, et al.
Published: (2023-07-01)

Renewed global threat by the novel SARS-CoV-2 variants ‘XBB, BF.7, BQ.1, BA.2.75, BA.4.6’: A discussion
by: Ranjan K. Mohapatra, et al.
Published: (2022-12-01)

Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant
by: Fabio Scarpa, et al.
Published: (2023-09-01)

Omicron variants of SARS-CoV-2: Epidemiological and clinical insights from a tertiary care center in Saudi Arabia
by: Bayan Dubaie, et al.
Published: (2024-06-01)

Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells
by: Revansiddha H. Katte, et al.
Published: (2024-03-01)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
by: David Niklas Springer, et al.
Published: (2023-07-01)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
by: Jianyang Liu, et al.
Published: (2023-12-01)

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
by: María I. Zapata-Cardona, et al.
Published: (2022-12-01)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
by: Xue-Jun Wang, et al.
Published: (2022-12-01)

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
by: Henning Jacobsen, et al.
Published: (2022-10-01)

Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients
by: Martina Brandolini, et al.
Published: (2023-01-01)

Comparison of the replication and neutralization of different SARS‐CoV‐2 Omicron subvariants in vitro
by: Yaqing Zhang, et al.
Published: (2023-02-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)